Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.
D000200:Action Potentials / Q000187:drug effects; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000526:Alprenolol / Q000627:therapeutic use; D001146:Arrhythmia, Sinus / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D006348:Cardiac Surgical Procedures / Q000009:adverse effects; D002395:Catecholamines / Q000627:therapeutic use; D003864:Depression, Chemical; D004071:Digitalis Glycosides / Q000009:adverse effects; D004562:Electrocardiography; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy; D010096:Oxprenolol / Q000627:therapeutic use; D010138:Pacemaker, Artificial; D010869:Pindolol / Q000627:therapeutic use; D011217:Practolol / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011690:Purkinje Fibers / Q000503:physiopathology; D013610:Tachycardia / Q000188:drug therapy; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy; D014693:Ventricular Fibrillation / Q000188:drug therapy; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D004071:Digitalis Glycosides; D010096:Oxprenolol; D000526:Alprenolol; D011433:Propranolol; D010869:Pindolol; D011217:Practolol